Article
Author(s):
The traditional packaging for frozen BDS applications has significant weaknesses at lower temperatures. This paper discusses new materials and freeze-thaw systems to meet these challenges.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.